SIR

Vishay Intertechnology Upgrades TFBS4xx and TFDU4xx Series IR Transceiver Modules With Longer Link Distance and Improved ESD Robustness

Retrieved on: 
Wednesday, March 13, 2024

MALVERN, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has upgraded its TFBS4xx and TFDU4xx series of infrared (IR) transceiver modules for IrDA® applications to offer 20 % longer link distance and improved ESD robustness to 2 kV.

Key Points: 
  • MALVERN, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has upgraded its TFBS4xx and TFDU4xx series of infrared (IR) transceiver modules for IrDA® applications to offer 20 % longer link distance and improved ESD robustness to 2 kV.
  • Devices in the Vishay Semiconductors TFBS4xxx and TFDU4xxx series each consist of a PIN photodiode, infrared emitter (IRED), and low power control IC in a single package.
  • And as drop-in replacements for existing devices, the modules help save costs by eliminating the need for PCB redesigns.
  • Compliant with the latest IrDA physical layer specification, TFBS4xxx and TFDU4xxx series devices are backward-compatible and are offered in top- and side-view surface-mount packages.

LIV Sotheby’s International Realty Names Nolan Carleton as Senior Vice President, Marketing and Communications

Retrieved on: 
Tuesday, March 26, 2024

LIV Sotheby’s International Realty (LIV SIR), Colorado’s premier real estate firm, is proud to announce that Nolan Carleton has been named as Senior Vice President, Marketing and Communications.

Key Points: 
  • LIV Sotheby’s International Realty (LIV SIR), Colorado’s premier real estate firm, is proud to announce that Nolan Carleton has been named as Senior Vice President, Marketing and Communications.
  • View the full release here: https://www.businesswire.com/news/home/20240326953489/en/
    LIV Sotheby’s International Realty (LIV SIR), Colorado’s premier real estate firm, announced Nolan Carleton has been named as Senior Vice President, Marketing and Communications.
  • Carleton, the latest addition to LIV SIR’s leadership team, is the most recent example.
  • Our talent strategy is reflective of that goal,” notes Shannel Ryan, President, Colorado, for LIV Sotheby’s International Realty.

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Retrieved on: 
Friday, March 22, 2024

GE HealthCare (Nasdaq: GEHC) will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, UT.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, UT.
  • The multi-modality showcase will feature innovations focused on precision care delivery for a wide range of vascular diseases and health conditions.
  • As GE HealthCare continues to advance the Allia IGS platform and interventional innovation, Embo ASSIST AI is the latest addition to the company's ASSIST imaging software.
  • “Interventional CT: CT guidance assisted by electromagnetic navigation for percutaneous interventions” with Dr. Francois Cornelis10 on Monday, March 25 from 2:30 - 3:00pm.

TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

Retrieved on: 
Thursday, March 21, 2024

The TriSalus approach seeks to address many of the key challenges associated with delivering therapeutics to pancreas tumors.

Key Points: 
  • The TriSalus approach seeks to address many of the key challenges associated with delivering therapeutics to pancreas tumors.
  • In contrast to the liver, pancreas arteries feeding tumors are difficult to access and venous access affords anatomic advantages.
  • Presentation details for SIR 2024 are as follows:
    Presentation: Clinical Efficacy of Pressure-Enabled Transarterial Embolization of Hypovascular, Treatment-Refractory Metastases.
  • Location: Salt Lake Palace Convention Center, Room 255B
    The presentations will be available on the publications page of the TriSalus website following the respective sessions.

Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

Retrieved on: 
Tuesday, March 5, 2024

SOUTH JORDAN, Utah, March 05, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today a series of events for clinicians attending the 2024 SIR Annual Meeting.

Key Points: 
  • SOUTH JORDAN, Utah, March 05, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today a series of events for clinicians attending the 2024 SIR Annual Meeting.
  • These educational events will take place at Merit’s headquarters and at SIR booth 320.
  • Throughout SIR, Merit will host the following educational events at booth 320:
    “PAE: Key Concepts in Patient Selection, Technical Success, and Optimizing Clinical Outcomes.”
    Register for these educational events.
  • “As a supporter of SIR, we share the organization’s commitment to educational opportunities and clinical research to advance the practice of interventional radiology.

NEW DATA: 70% OF AMERICANS UNAWARE OF COMMON VASCULAR DISEASE THAT IS ONE OF THE LEADING CAUSES OF AMPUTATION

Retrieved on: 
Thursday, February 8, 2024

WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- According to a new national survey released today by the PAD Pulse Alliance, 70% of Americans are unaware of peripheral artery disease (PAD) – the most common vascular disease in which leg arteries become narrowed, reducing or cutting off blood flow, contributing to 400 amputations performed each day in the United States. The top risk factors for PAD are common chronic health conditions that disproportionately impact underserved communities. Yet among Black and Hispanic adults, nearly 80% report never having a doctor or healthcare provider discuss PAD with them – underscoring the need to start the conversation.

Key Points: 
  • The top risk factors for PAD are common chronic health conditions that disproportionately impact underserved communities.
  • That's why we're encouraging anyone with leading risk factors, diabetes, high blood pressure and use of tobacco products, to know your 'three for PAD' and talk to your doctor."
  • Data from the PAD Pulse Alliance survey highlights a disconnect among people between the risk factors and their personal perceived risk of PAD.
  • Nearly eight in 10 Black and Hispanic never had a doctor or healthcare provider talk with them about PAD.

LIV Sotheby's International Realty Announces New Leadership Roles in Colorado

Retrieved on: 
Wednesday, January 17, 2024

Today, LIV SIR announces a significant leadership transition that marks a new era for the company.

Key Points: 
  • Today, LIV SIR announces a significant leadership transition that marks a new era for the company.
  • Taking over as the new President of LIV Sotheby’s International Realty Colorado is Shannel Ryan.
  • LIV SIR’s Colorado resorts will maintain their strong local leadership with in-market expertise, deep-rooted relationships, and unwavering community ties.
  • Coupled with the global brand cache of Sotheby’s International Realty (SIR), this collaboration across Colorado will continue to amplify LIV SIR’s success.

FOOD FIRST: Jack Astor’s Unveils New Raw, Real and Relatable Campaign that Celebrates its Self-Proclaimed ‘Annoyingly High Food Standards’

Retrieved on: 
Monday, January 15, 2024

They take extra steps and care to make food the right way, the annoying way, and that makes all the difference in the final quality,” said Eady.

Key Points: 
  • They take extra steps and care to make food the right way, the annoying way, and that makes all the difference in the final quality,” said Eady.
  • Reflecting Jack Astor's commitment to authenticity, the campaign further defies norms by casting its own hourly team members and managers – not a single professional actor was used.
  • All are current SIR Corp Kitchen employees, including pantry and line cooks, kitchen managers and the brand’s Culinary Director.
  • The authentic, gritty campaign marks another instance of a 30+ years tradition of Jack Astor’s breaking conventions followed by typical chain restaurants.

Research Unveils Genetic Basis for S-Metolachlor Resistance in Waterhemp

Retrieved on: 
Tuesday, January 16, 2024

WESTMINSTER, Colo., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Recently published research in the journal Weed Science provides new mechanistic insights into S-metolachlor resistance in waterhemp (Amaranthus tuberculatus). Specifically, the study points to a single major gene that controls metabolic resistance to S-metolachlor (the active ingredient in Dual Magnum and Dual II Magnum), in the Stanford, Illinois resistant (SIR) population, which represents a relatively new and recent type of non-target-site resistance in waterhemp - to soil-applied, Group 15 herbicides. 

Key Points: 
  • A newly published Weed Science Society of America research article identifies a single major gene controlling S-metolachlor resistance in a central Illinois waterhemp population, which represents a relatively new and recent type of non-target-site resistance in waterhemp - to soil-applied, Group 15 herbicides.
  • WESTMINSTER, Colo., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Recently published research in the journal Weed Science provides new mechanistic insights into S-metolachlor resistance in waterhemp (Amaranthus tuberculatus).
  • "Waterhemp has developed resistance to seven herbicide sites-of-action classes, creating extremely difficult management challenges to farmers."
  • The good news is that the germplasm derived from this research can assist in identifying the gene(s) and gene mutations conferring resistance to S-metolachlor in waterhemp.

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Retrieved on: 
Tuesday, December 19, 2023

(Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced the acceptance of a clinical data abstract for the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting , held March 23-28 in Salt Lake City, Utah.

Key Points: 
  • (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced the acceptance of a clinical data abstract for the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting , held March 23-28 in Salt Lake City, Utah.
  • “We are pleased to present research supporting our TAMP therapy platform at the upcoming SIR 2024 conference, the largest professional gathering of interventional radiologists in North America,” said Shaun Bagai, CEO of RenovoRx.
  • “This research adds to the continued progress of our pivotal Phase III TIGeR-PaC study in LAPC.
  • We remain steadfast in our commitment to deliver transformative therapies to potentially extend and improve the quality of life of cancer patients.”